The Health Resources and Services Administration should abandon its consideration of a 340B rebate model pilot program ...
The AHA responds to the Health Resources and Services Administration’s (HRSA) Request for Information regarding a potential 340B Rebate Model Pilot Program.
The American Hospital Association has urged the Health Resources and Services Administration to abandon its consideration of the 340B rebate model pilot program, arguing the approach would impose ...
While it may be hard to believe, there is one issue in Washington that meets the above criteria: fixing the 340B program.
The federal program was created in 1992 to help hospitals and clinics in poor communities. In recent weeks, it has become the ...
In the Bronx, healthcare isn’t abstract. It’s personal. It’s the senior choosing between filling a prescription or paying for ...
In February 2026, the Department of Justice filed amicus briefs supporting pharmaceutical manufacturers, asserting that Rhode ...
Court challenges against a new Washington law shine a spotlight on the issues of drug prices, the fragile state of American health care, and constitutional powers. In other words, they touch upon sign ...
Cutting the 340B drug discount program won't save money — it will just shift the bill from Big Pharma to taxpayers while closing rural hospitals.
The Maximum Fair Price (MFP), established by the Inflation Reduction Act, allows CMS to negotiate prices for Medicare drugs.
Lawmakers in Albany are considering legislation that would reinforce and expand 340B. They must pause that effort and instead ...
Hospitals are abusing a federal charity program to acquire prescription drugs at a discount — and then reselling those medications at outrageous markups.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results